David Shuey
Medical · Emmett, IDNPI 1730276445
Payments from drug & device makers
Across 60 payments — averaging $20.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$198
- Novo Nordisk$138
- AbbVie$118
- Novartis$112
- Phathom Pharmaceuticals, Inc.$111
- Lilly USA, LLC$59
- plus $478 from 18 others
What the payments were for
- Food & beverage$1,214100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 7 | $198 |
| Novo Nordisk | 8 | $138 |
| AbbVie | 6 | $118 |
| Novartis | 6 | $112 |
| Phathom Pharmaceuticals, Inc. | 1 | $111 |
| Lilly USA, LLC | 4 | $59 |
| Pfizer | 3 | $55 |
| Bayer | 3 | $51 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $44 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Astellas Pharma US Inc | 2 | $39 |
| Amgen | 2 | $33 |
| GSK | 2 | $33 |
| Viatris Specialty LLC | 1 | $22 |
| Lucid Diagnostics Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $12 |
| Genentech USA, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOQUEZNA$111
How this compares
$1,214 in reported general payments places this provider in the 70th percentile of 265 medical providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 46 | $36,605 |
| OzempicSemaglutide | 39 | $36,554 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $33,144 |
| FarxigaDapagliflozin Propanediol | 12 | $17,508 |
| LinzessLinaclotide | 11 | $7,893 |
| MyrbetriqMirabegron | 11 | $4,851 |
| Meprobamate | 11 | $3,415 |
| Olanzapine | 32 | $2,013 |
| Chlorpromazine Hcl | 11 | $1,882 |
| Naproxen | 20 | $1,825 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 70 | $1,796 |
| Fluticasone Propionate | 71 | $1,582 |
| Omeprazole | 100 | $1,580 |
| Duloxetine Hcl | 86 | $1,554 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $1,536 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $55 | $36,60546 claims |
| Novo NordiskOzempic | $138 | $36,55439 claims |
| GSKTrelegy Ellipta | $33 | $33,14439 claims |
| AstraZenecaFarxiga | $198 | $17,50812 claims |
| AbbVieLinzess | $118 | $7,89311 claims |
| Astellas Pharma US IncMyrbetriq | $39 | $4,85111 claims |
| Lilly USA, LLCOlanzapine | $59 | $2,01332 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 265 medical providers in Idaho.
Other medical in Emmett
- Brett ZundelTerreton$71K
- Jessica BishopBoise$60K
- Kyle GeorgeMeridian$19K
- Jed BartschiIdaho Falls$11K
- Dallin GamblesRexburg$10K
- Cali BradberryBoise$9K
- Weldon RichardsonIdaho Falls$8K
- Michael WucinichTwin Falls$8K
- Wade ChristensenIdaho Falls$8K
- Joshua HansenIdaho Falls$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.